Skip to main content
Caplight Logo









OrganAID Holdings

OrganAID Holdings

Private
BarcelonaHealthcare & Life Scienceshttps://organaid.eu/

Last Round

Grant

Oct 17, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OrganAID Holdings is a biotechnology company that develops a drug-testing platform using brain organoids derived from patient cells and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

patient-derived organoidsorganoid drug screeningAI drug discoveryCRO servicesdrug toxicity testinganimal model alternativesbrain organoidspreclinical testingpersonalized medicinetissue avatarsorgan-on-a-chipdrug efficacy testingoncology drug discoveryneurology drug discoveryneurotoxicity testingiPSC organoids

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganAID Holdings Comparables

Compare OrganAID Holdings with similar companies based on industry and business-model similarity.

OrganAID Holdings comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProxyBio
84%
Vivodyne
84%
CELLphenomics GmbH
79%

OrganAID Holdings Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 17, 2025

Key People

Founding team and executive leadership

Sandra Acosta

Chief Scientific Officer And Founder

Founding Team

OrganAID Holdings Investors

Notable investors and investment history

OrganAID Holdings investors
InvestorRounds
Pompeu Fabra UniversityGrant
University of BarcelonaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 17, 2025

    Received grant funding from "la Caixa" Foundation and universities.

OrganAID Holdings Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OrganAID Holdings Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OrganAID Holdings's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range1
Year Founded2025
Last FundingOct 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?